3 nominees · 5 ballot items.
Elect three Class III directors; ratify Deloitte & Touche LLP as independent auditors; non-binding advisory vote to approve named executive officer compensation; amend certificate to increase authorized common shares from 600,000,000 to 800,000,000; and amend the 2020 Incentive Plan to add 5,000,000 shares and increase the ISO limit by 5,000,000 shares.
Elect three Class III directors (Jeff Bornstein, Claude Demby, and Nathaniel Fick) each to serve three-year terms until their successors are elected and qualified.
Ratify the Audit Committee’s selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.
This non-binding say-on-pay proposal asks shareholders to approve the compensation awarded to the named executive officers as disclosed in the proxy. Management frames the vote as an accountability mechanism: while advisory and not binding, the Board and Compensation Committee state they will consider the outcome in future compensation decisions. The Board argues the programs support business objectives, align pay with company and individual performance, avoid incentives for excessive risk-taking, provide competitive compensation, and promote retention. In evaluating this proposal, an analyst should weigh the company’s emphasis on long-term equity and performance-based PRSUs, recent compensation changes (including expanded PRSUs and double-trigger change-in-control provisions), and the substantial equity-based elements that can create strong pay-for-performance linkage but also lead to realized pay variability tied to stock price. The company reports no annual bonuses paid in 2025 and significant equity awards to executives, including RSUs and PRSUs tied to rTSR and company performance metrics, which were not earned in 2025 for company PRSUs; this context matters for assessing whether pay outcomes reflect performance. The advisory nature means even a negative vote would not directly change compensation, but could prompt board and Compensation Committee actions and investor engagement; the company has signaled responsiveness to shareholder feedback in recent compensation changes. For governance-minded investors, the key questions are whether performance measures are sufficiently demanding and long-term, whether equity grant sizes are reasonable versus peers, and whether compensation design appropriately balances retention with incentives to drive operational results and shareholder return. The Board’s recommendation to vote FOR is based on its view that the current structure aligns with stockholder interests, but sophisticated investors should examine the detailed compensation tables, PRSU performance metrics, and historical pay-versus-performance outcomes when forming a vote decision.
Approve an amendment to the Third Amended and Restated Certificate of Incorporation to increase authorized common stock from 600,000,000 shares to 800,000,000 shares.
This proposal asks shareholders to authorize an increase of the Company’s authorized common stock by 200 million shares (from 600 million to 800 million), effected by amending Section 4.1(b) of the Certificate of Incorporation. Management states the primary near-term driver is to ensure sufficient authorized shares to allow optional stock settlement of the November 2025 Convertible Notes (maximum conversion of ~46.95 million shares) and to avoid large cash repayments that would be required if conversions could only be settled in cash. The Board also cites routine corporate flexibility reasons—equity incentives, potential acquisitions, financings, stock splits/dividends, and other corporate purposes—as drivers for the increase. The proposal would dilute existing shareholders if the new shares are issued, and the company discloses that additional issuance could affect EPS, book value per share, and voting power; the Board claims it does not propose the increase to entrench management but to preserve operational and financing optionality. From a governance perspective, investors should consider the size of the increase relative to outstanding shares (approximately 200M additional vs ~337M outstanding as of Dec 31, 2025), the Company’s current capital needs and debt maturity profile, the potential for opportunistic issuance, and any limits or commitments management offers regarding future issuance. Also relevant is the presence of substantial reserved shares for Cerberus financing and other instruments; the Board’s stated intent to reserve shares necessary for convertible note conversions matters to preserving conversion optionality. The transaction-specific rationale (avoiding cash settlement of convertible notes) is a strong near-term justification, but long-term dilution risk and governance protections (e.g., preemptive rights or issuance caps) should be evaluated by sophisticated investors.
Approve amendments to the Second Amended and Restated 2020 Incentive Plan to increase the shares reserved for issuance under the plan by 5,000,000 shares and increase the limit on shares available for incentive stock options by 5,000,000 shares.
This management proposal requests shareholder approval to add 5,000,000 shares to the company’s 2020 Incentive Plan share reserve (and to increase the ISO limit by the same amount), asserting that the current reserve is insufficient to support ongoing equity-based awards used for retention and incentive purposes. Management frames the increase as necessary to conserve cash while continuing competitive compensation through equity grants; the Compensation Committee reviewed peer dilution and concluded the increase is reasonable. An analyst should note the plan already includes many governance-friendly provisions (no evergreen, anti-repricing without shareholder approval, limits on director compensation, double-trigger change-in-control treatment for employees, and recycling prohibitions), which mitigate some dilution and governance concerns. The filing quantifies that post-approval the total authorized under the plan would be 46,035,887 shares and that basic dilution from the requested increase would be roughly 8.1%, down from prior years’ higher requested dilution percentages, indicating improved dilution metrics versus prior increases. Key investor considerations include the pace of equity grants historically, the company’s hiring and retention needs, the potential dilutive impact relative to total outstanding shares and to likely future financings, and whether awards are structured with performance metrics and vesting terms that align with long-term shareholder value. Given management’s emphasis on pay-for-performance and the use of PRSUs tied to relative TSR and company metrics, the proposed increase can be seen as sustaining a compensation program that ties pay to performance, but investors should monitor grant sizes and overall dilution over time. The Board recommends a vote FOR the amendment, arguing the additional shares are necessary to attract and retain talent and align employee incentives with stockholder interests.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DRIEHAUS CAPITAL MANAGEMENT LLC | 4.38% | 14,869,170 | $74M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4.37% | 14,835,437 | $74M |
| 3 | TWO SIGMA INVESTMENTS, LP | 4.15% | 14,074,001 | $70M |
| 4 | BlackRock, Inc. | 3.25% | 11,037,985 | $55M |
| 5 | BlackRock, Inc. | 2.80% | 9,498,476 | $47M |
| 6 | STATE STREET CORP | 2.36% | 8,017,930 | $40M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.97% | 6,695,733 | $33M |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.87% | 6,350,481 | $31M |
| 9 | CITADEL ADVISORS LLC | 1.80% | 6,100,772 | $30M |
| 10 | Electron Capital Partners, LLC | 1.58% | 5,379,661 | $27M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.